136 related articles for article (PubMed ID: 29929445)
1. Hyperandrogenism Induces Histo-Architectural Changes in the Rat Uterus.
Bracho GS; Altamirano GA; Kass L; Luque EH; Bosquiazzo VL
Reprod Sci; 2019 May; 26(5):657-668. PubMed ID: 29929445
[TBL] [Abstract][Full Text] [Related]
2. Androgen receptor and uterine histoarchitecture in a PCOS rat model.
Gisela S B; M Virginia A; Gabriela A A; M Virginia T; Enrique H L; Laura K; Véronica L B
Mol Cell Endocrinol; 2020 Dec; 518():110973. PubMed ID: 32781251
[TBL] [Abstract][Full Text] [Related]
3. Metformin Ameliorates Uterine Defects in a Rat Model of Polycystic Ovary Syndrome.
Zhang Y; Hu M; Meng F; Sun X; Xu H; Zhang J; Cui P; Morina N; Li X; Li W; Wu XK; Brännström M; Shao R; Billig H
EBioMedicine; 2017 Apr; 18():157-170. PubMed ID: 28336389
[TBL] [Abstract][Full Text] [Related]
4. The anti-androgenic effect of quercetin on hyperandrogenism and ovarian dysfunction induced in a dehydroepiandrosterone rat model of polycystic ovary syndrome.
Mahmoud AA; Elfiky AM; Abo-Zeid FS
Steroids; 2022 Jan; 177():108936. PubMed ID: 34752810
[TBL] [Abstract][Full Text] [Related]
5. Increased uterine androgen receptor protein abundance results in implantation and mitochondrial defects in pregnant rats with hyperandrogenism and insulin resistance.
Zhang Y; Hu M; Yang F; Zhang Y; Ma S; Zhang D; Wang X; Sferruzzi-Perri AN; Wu X; Brännström M; Shao LR; Billig H
J Mol Med (Berl); 2021 Oct; 99(10):1427-1446. PubMed ID: 34180022
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the Rho A/Rho-kinase pathway in the uterus of the rat model of polycystic ovary syndrome.
Aktas S; Un I; Omer Barlas I; Ozturk AB; Ilkay Karagul M
Reprod Biol; 2019 Mar; 19(1):45-54. PubMed ID: 30704840
[TBL] [Abstract][Full Text] [Related]
7. The use of dehydroepiandrosterone-treated rats is not a good animal model for the study of metabolic abnormalities in polycystic ovary syndrome.
Seow KM; Ting CH; Huang SW; Ho LT; Juan CC
Taiwan J Obstet Gynecol; 2018 Oct; 57(5):696-704. PubMed ID: 30342654
[TBL] [Abstract][Full Text] [Related]
8. Detrimental effects of hyperandrogenism on uterine functions.
Elia E; Vighi S; Lombardi E; Motta AB
Int Immunopharmacol; 2008 Dec; 8(13-14):1827-34. PubMed ID: 18817896
[TBL] [Abstract][Full Text] [Related]
9. Dehydroepiandrosterone induces ovarian and uterine hyperfibrosis in female rats.
Zhang X; Zhang C; Shen S; Xia Yj; Yi L; Gao Q; Wang Y
Hum Reprod; 2013 Nov; 28(11):3074-85. PubMed ID: 23980058
[TBL] [Abstract][Full Text] [Related]
10. Chronic hyperandrogenemia in the presence and absence of a western-style diet impairs ovarian and uterine structure/function in young adult rhesus monkeys.
Bishop CV; Mishler EC; Takahashi DL; Reiter TE; Bond KR; True CA; Slayden OD; Stouffer RL
Hum Reprod; 2018 Jan; 33(1):128-139. PubMed ID: 29190387
[TBL] [Abstract][Full Text] [Related]
11. Deficiency of Gpr1 improves steroid hormone abnormality in hyperandrogenized mice.
Yang YL; Sun LF; Yu Y; Xiao TX; Wang BB; Ren PG; Tang HR; Zhang JV
Reprod Biol Endocrinol; 2018 May; 16(1):50. PubMed ID: 29793502
[TBL] [Abstract][Full Text] [Related]
12. Amelioration by quercetin of insulin resistance and uterine GLUT4 and ERα gene expression in rats with polycystic ovary syndrome (PCOS).
Neisy A; Zal F; Seghatoleslam A; Alaee S
Reprod Fertil Dev; 2019 Jan; 31(2):315-323. PubMed ID: 30103849
[TBL] [Abstract][Full Text] [Related]
13. Effects of oral administration of tamoxifen, toremifene, dehydroepiandrosterone, and vorozole on uterine histomorphology in the rat.
Nephew KP; Osborne E; Lubet RA; Grubbs CJ; Khan SA
Proc Soc Exp Biol Med; 2000 Mar; 223(3):288-94. PubMed ID: 10719842
[TBL] [Abstract][Full Text] [Related]
14. Clustering of PCOS-like traits in naturally hyperandrogenic female rhesus monkeys.
Abbott DH; Rayome BH; Dumesic DA; Lewis KC; Edwards AK; Wallen K; Wilson ME; Appt SE; Levine JE
Hum Reprod; 2017 Apr; 32(4):923-936. PubMed ID: 28333238
[TBL] [Abstract][Full Text] [Related]
15. Adrenal hyperandrogenism is induced by fetal androgen excess in a rhesus monkey model of polycystic ovary syndrome.
Zhou R; Bird IM; Dumesic DA; Abbott DH
J Clin Endocrinol Metab; 2005 Dec; 90(12):6630-7. PubMed ID: 16174719
[TBL] [Abstract][Full Text] [Related]
16. Haplosufficient genomic androgen receptor signaling is adequate to protect female mice from induction of polycystic ovary syndrome features by prenatal hyperandrogenization.
Caldwell AS; Eid S; Kay CR; Jimenez M; McMahon AC; Desai R; Allan CM; Smith JT; Handelsman DJ; Walters KA
Endocrinology; 2015 Apr; 156(4):1441-52. PubMed ID: 25643156
[TBL] [Abstract][Full Text] [Related]
17. Investigation of the uterine structural changes in the experimental model with polycystic ovary syndrome and effects of vitamin D treatment: An ultrastructural and immunohistochemical study.
Kuyucu Y; Çelik LS; Kendirlinan Ö; Tap Ö; Mete UÖ
Reprod Biol; 2018 Mar; 18(1):53-59. PubMed ID: 29325695
[TBL] [Abstract][Full Text] [Related]
18. Expression of PPAR-γ in adipose tissue of rats with polycystic ovary syndrome induced by DHEA.
Wang YX; Zhu WJ; Xie BG
Mol Med Rep; 2014 Mar; 9(3):889-93. PubMed ID: 24425206
[TBL] [Abstract][Full Text] [Related]
19. Quercetin modulates granulosa cell mRNA androgen receptor gene expression in dehydroepiandrosterone-induced polycystic ovary in Wistar rats via metabolic and hormonal pathways.
Olaniyan OT; Bamidele O; Adetunji CO; Priscilla B; Femi A; Ayobami D; Okotie G; Oluwaseun I; Olugbenga E; Mali PC
J Basic Clin Physiol Pharmacol; 2020 Mar; 31(4):. PubMed ID: 32160160
[TBL] [Abstract][Full Text] [Related]
20. Animal models of hyperandrogenism and ovarian morphology changes as features of polycystic ovary syndrome: a systematic review.
Paixão L; Ramos RB; Lavarda A; Morsh DM; Spritzer PM
Reprod Biol Endocrinol; 2017 Feb; 15(1):12. PubMed ID: 28183310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
